Clicky

Intelligent Bio Solutions Inc.(INBS)

Description: Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.


Keywords: Medicine Biotechnology Diabetes Tumor Monitoring Diagnostic Tests Glucose Real Time Monitoring Diabetes Management Biosensors

Home Page: ibs.inc

INBS Technical Analysis

142 West 57th Street
New York, NY 10019
United States
Phone: 646 828 8258


Officers

Name Title
Mr. Harry Simeonidis Pres & CEO
Mr. Spiro Kevin Sakiris B.Bus, C.A., CA, Dip Law Chief Financial Officer
Ms. Victoria Gavrilenko Operations Mang.
Mr. Alex Arzeno VP of Investor Relations

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.2153
Price-to-Sales TTM: 8.5798
IPO Date: 2020-12-23
Fiscal Year End: June
Full Time Employees: 12
Back to stocks